Literature DB >> 9668290

Anti-titin and antiryanodine receptor antibodies in myasthenia gravis patients with thymoma.

F Baggi1, F Andreetta, C Antozzi, O Simoncini, P Confalonieri, S Labeit, F Cornelio, R Mantegazza.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9668290     DOI： 10.1111/j.1749-6632.1998.tb10978.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  11 in total

1.  Measurement of antiacetylcholine receptor antibody in patients with thymoma without myasthenia gravis complications.

Authors:  M Sakuraba; T Onuki; S Nitta
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-12

2.  Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis.

Authors:  Chengyong Shen; Yisheng Lu; Bin Zhang; Dwight Figueiredo; Jonathan Bean; Jiung Jung; Haitao Wu; Arnab Barik; Dong-Min Yin; Wen-Cheng Xiong; Lin Mei
Journal:  J Clin Invest       Date:  2013-11-08       Impact factor: 14.808

Review 3.  Anti-myelin oligodendrocyte glycoprotein antibodies: Magnetic resonance imaging findings in a case series and a literature review.

Authors:  Michaela Cellina; Vincenza Fetoni; Matteo Ciocca; Marta Pirovano; Giancarlo Oliva
Journal:  Neuroradiol J       Date:  2017-04-05

Review 4.  Myasthenia gravis: past, present, and future.

Authors:  Bianca M Conti-Fine; Monica Milani; Henry J Kaminski
Journal:  J Clin Invest       Date:  2006-11       Impact factor: 14.808

5.  The significance of titin antibodies in myasthenia gravis--correlation with thymoma and severity of myasthenia gravis.

Authors:  Xiang-Jun Chen; Jian Qiao; Bao-Guo Xiao; Chuan-Zhen Lu
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

6.  Myasthenia Gravis.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-07       Impact factor: 3.972

7.  Thymoma in myasthenia gravis: from diagnosis to treatment.

Authors:  Fredrik Romi
Journal:  Autoimmune Dis       Date:  2011-08-10

Review 8.  Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management.

Authors:  Konstantinos Lazaridis; Socrates J Tzartos
Journal:  Front Neurol       Date:  2020-11-30       Impact factor: 4.003

9.  Myasthenia gravis: analysis of serum autoantibody reactivities to 1827 potential human autoantigens by protein macroarrays.

Authors:  Anne Becker; Nicole Ludwig; Andreas Keller; Björn Tackenberg; Christian Eienbröker; Wolfgang H Oertel; Klaus Fassbender; Eckart Meese; Klemens Ruprecht
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

Review 10.  Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics.

Authors:  Konstantinos Lazaridis; Socrates J Tzartos
Journal:  Front Immunol       Date:  2020-02-14       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.